scholarly journals The Quality of Life after Laparoscopic Pyeloplasty due to Ureteropelvic Junction Obstruction: Assessment After Long Term Observation.

2020 ◽  
Author(s):  
Wojciech Panek ◽  
Dawid Janczak ◽  
Marta Panek ◽  
Urszula Szydełko ◽  
Rafał Chrzan ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Functional Outcome ◽  
Ureteropelvic Junction Obstruction ◽  
Treatment Effectiveness ◽  
Ureteropelvic Junction ◽  
Professional Activity ◽  
Laparoscopic Pyeloplasty ◽  
Long Term Observation ◽  
The Impact

Abstract Background: A change in the assessment of treatment effectiveness is currently observed. More and more emphasis is being placed on assessing the impact of treatment on patients’ quality of life (QoL). Data on postoperative quality of life in patients undergoing pyeloplasty is scarce. The aim of the study was to assess the quality of life of patients who had undergone laparoscopic pyeloplasty due to ureteropelvic junction obstruction.Methods: The study group consisted of 95 patients who had consecutively undergone laparoscopic pyeloplasty due to ureteropelvic junction obstruction in a single center, between 2002 and 2009, from whom 26 consented to participate in a study. We evaluated their quality of life using WHOQOL-BREF questionnaire and an additional form, created by one of the authors, prepared to assess specifically health related quality of life after pyeloplasty. In all the patients, postoperative, functional outcome was assessed using diuretic renography. Results: Mean follow-up time was 89.8 months. Overall, 96% of study patients were satisfied with the procedure and all of them would consent to another pyeloplasty if needed. Dissatisfaction of one patient was caused by an insufficient decrease in pain level. All the patients reported that the postoperative pain intensity did not significantly affect their life and professional activity. Conclusions: Laparoscopic pyeloplasty is associated with excellent functional outcomes and - most of all - the majority of patients are satisfied with the treatment results. There seems to be no correlation between functional outcome and postoperative satisfaction.

Prospective Evaluation of Health Related Quality of Life for Pediatric Patients With Ureteropelvic Junction Obstruction

2008 ◽  
Vol 180 (5) ◽  
pp. 2171-2176 ◽  
Author(s):  
Amruta Dipen Parekh ◽  
John C. Thomas ◽  
Lisa Trusler ◽  
Donna P. Ankerst ◽  
Jayant K. Deshpande ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Pediatric Patients ◽  
Ureteropelvic Junction Obstruction ◽  
Ureteropelvic Junction ◽  
Prospective Evaluation ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related

scholarly journals Long-term health-related quality of life, survival and costs by different levels of functional outcome six months after stroke

2018 ◽  
Vol 3 (2) ◽  
pp. 157-164 ◽  
Author(s):  
Ann-Sofie Rudberg ◽  
Eivind Berge ◽  
Anders Gustavsson ◽  
Per Näsman ◽  
Erik Lundström
Keyword(s):  
Quality Of Life ◽  
Functional Outcome ◽  
Economic Evaluations ◽  
Health Related Quality ◽  
Term Survival ◽  
Related Quality ◽  
Health Related ◽  
The Impact

Introduction Information about the impact of functional outcome after stroke is currently missing on health-related quality of life, survival and costs. This information would be valuable for health economic evaluations and for allocation of resources in stroke health care. Patients and methods Data on 297 Swedish patients included in the Third International Stroke Trial were analysed including functional outcome at six months (measured by Oxford Handicap Scale), health-related quality of life up to 18 months (EQ-5D-3L) and survival up to 36 months. We used record linkage to collect data on costs up to 36 months, using national patient registers. Results Patients with a better functional outcome level at six months had a significantly better health-related quality of life at 18 months ( p < 0.05), better long-term survival ( p < 0.05) and lower costs ( p < 0.001), for all time points up to 36 months. The difference in costs was mainly due to differences in days spent in hospital ( p < 0.005). Discussion This study showed an association between functional outcome at six months and health-related quality of life up to 18 months, and costs up to 36 months. Conclusion Functional outcome six months after stroke is an important determinant of health-related quality of life, survival and costs over 36 months. Effective interventions aimed at reducing short-term disability levels are therefore also expected to reduce the overall burden of stroke.

Plating for midshaft clavicular fractures: The impact on quality of life and functional outcome

Injury ◽  
2017 ◽  
Vol 48 (12) ◽  
pp. 2778-2783 ◽  
Author(s):  
Rens A. van der Linde ◽  
Ivo Beetz ◽  
Sven H. van Helden
Keyword(s):  
Quality Of Life ◽  
Functional Outcome ◽  
The Impact

78: Prospective evaluation of health related quality of life(HRQOL) in ureteropelvic junction obstruction(UPJO)

2007 ◽  
Vol 177 (4S) ◽  
pp. 27-27
Author(s):  
Amruta D. Parekh ◽  
Lisa A. Trusler ◽  
Donna P. Ankesrt ◽  
John C. Pope ◽  
Romano T. DeMarco ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Ureteropelvic Junction Obstruction ◽  
Ureteropelvic Junction ◽  
Prospective Evaluation ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related

scholarly journals Efficacy of switching from infliximab to golimumab in patients with ulcerative colitis in deep remission

2021 ◽  
Vol 84 (3) ◽  
Author(s):  
N Viazis ◽  
C Pontas ◽  
A Manolakis ◽  
G Karampekos ◽  
E Tsoukali ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Ulcerative Colitis ◽  
Pilot Study ◽  
Treatment Effectiveness ◽  
Work Productivity ◽  
Control Group ◽  
Endoscopic Remission ◽  
Satisfaction With Treatment ◽  
The Impact

Background-Aim : Intravenously administered biologicals are associated with a huge pressure to Infusion Units and increased cost. We aimed to assess the impact of switching infliximab to golimumab in ulcerative colitis (UC) patients in deep remission. Patients and method : In a prospective, single-centre pilot study UC patients on infliximab mono-therapy for ≥ 2 years, whowere in deep remission, consented to switch to golimumab and were followed for 1 year with clinical assessment, serum and faecal biomarkers, work productivity, satisfaction with treatment and quality of life parameters. Endoscopic remission was assessed by colonoscopy at 1 year. Patients fulfilling the same inclusion criteria, who did not consent to switch to golimumab and continued to receive infliximab mono-therapy, for the same period, served as controls. Results : Between October 2015 and October 2017, 20 patients were recruited; however one patient stopped therapy because of pregnancy. All 19 patients who were switched to golimumab were still in clinical, biomarker and endoscopic remission at 1 year and maintained excellent quality of life without any complications. In the control group, 18 of 19 patients were also in deep remission, since only one patient had a flare which was managed with IFX dose intensification. During a median 3 years extension treatment with golimumab only 2 patients experienced a flare of colitis. Conclusions : This pilot study indicates that switching from in-fliximab to golimumab in UC patients in deep remission does not compromise treatment effectiveness or the course of disease; golimumab offers a valid alternative to intravenous infliximab infusions during the COVID-19 pandemic.

Self-Compassion and Quality of Life in Adults Who Stutter

2020 ◽  
Vol 29 (4) ◽  
pp. 2097-2108
Author(s):  
Robyn L. Croft ◽  
Courtney T. Byrd
Keyword(s):  
Quality Of Life ◽  
Social Connectedness ◽  
The Self ◽  
Future Research ◽  
Self Compassion ◽  
Adults Who Stutter ◽  
And Gender ◽  
Relationship Of ◽  
The Impact

Purpose The purpose of this study was to identify levels of self-compassion in adults who do and do not stutter and to determine whether self-compassion predicts the impact of stuttering on quality of life in adults who stutter. Method Participants included 140 adults who do and do not stutter matched for age and gender. All participants completed the Self-Compassion Scale. Adults who stutter also completed the Overall Assessment of the Speaker's Experience of Stuttering. Data were analyzed for self-compassion differences between and within adults who do and do not stutter and to predict self-compassion on quality of life in adults who stutter. Results Adults who do and do not stutter exhibited no significant differences in total self-compassion, regardless of participant gender. A simple linear regression of the total self-compassion score and total Overall Assessment of the Speaker's Experience of Stuttering score showed a significant, negative linear relationship of self-compassion predicting the impact of stuttering on quality of life. Conclusions Data suggest that higher levels of self-kindness, mindfulness, and social connectedness (i.e., self-compassion) are related to reduced negative reactions to stuttering, an increased participation in daily communication situations, and an improved overall quality of life. Future research should replicate current findings and identify moderators of the self-compassion–quality of life relationship.

840: Laparoscopic Pyeloplasty for Ureteropelvic Junction Obstruction: Comparing Davinci Robotic to Classic Laparoscopic Pyeloplasty

2005 ◽  
Vol 173 (4S) ◽  
pp. 228-228
Author(s):  
Scott V. Burgess ◽  
Michael M. Woods ◽  
Freddy Mendez-Torres ◽  
Erik P. Castle ◽  
Raju Thomas
Keyword(s):  
Ureteropelvic Junction Obstruction ◽  
Ureteropelvic Junction ◽  
Laparoscopic Pyeloplasty
Sign in / Sign up

Export Citation Format

Share Document